New Research Initiative Aims to Prevent Breast Cancer
The National Breast Cancer Coalition is pushing for policy changes to speed disability benefits for metastatic patients.
Updated on Oct. 28, 2026 in Cancer
Live Poll
Should government-mandated waiting periods for metastatic cancer patients' disability benefits be permanently eliminated?
The National Breast Cancer Coalition has launched the Artemis Project, a new research initiative aiming to develop cancer prevention models independently of pharmaceutical or government funding. The organization is also advocating for federal legislation to eliminate waiting periods for disability benefits for patients with metastatic breast cancer.
Why it matters
By relying solely on grassroots philanthropy, the coalition seeks to maintain total control over its research agenda, including the development of a preventative vaccine. Simultaneously, the push to remove federal waiting periods aims to grant patients faster access to critical financial support and care.
Current federal policies enforce a 24-month Medicare and 5-month Social Security waiting period for metastatic breast cancer patients, vs. the proposed immediate access. The development of a preventative vaccine is currently in the planning stage, with phase 1 trials expected by 2026.
The players
National Breast Cancer Coalition
A national advocacy organization that works to end breast cancer through research, public policy, and clinical trial education.
Fran Visco
A 30-year cancer survivor and leader within the advocacy community.
UCLA
A major public research university that has partnered with advocacy groups on previous medical research discoveries.
The details
The Artemis Project functions by bypassing traditional industry-backed funding models to avoid conflicts of interest, relying instead on grassroots donations and annual events. The organization previously demonstrated the impact of independent research by accelerating the availability of CDA inhibitor drugs by two years in partnership with UCLA researchers. The group is now prioritizing a preventative vaccine, with plans to advance this to clinical testing to address cancer development at its earliest biological stage.
Timeline
October 2026: The organization hosted its annual fundraiser at Paramount Studios.
By December 31, 2026: The Artemis Project plans to launch a phase 1 clinical trial for a preventative vaccine.
Health Landscape
This effort sits at the intersection of long-standing federal disability policy and the evolving push for patient-led research initiatives. It highlights a departure from traditional industry-funded research pipelines in favor of independent, advocacy-driven clinical development.
Patients with a metastatic breast cancer diagnosis should speak with a physician or social worker regarding the current federal waiting periods for disability benefits. Those interested in research advocacy may look for opportunities to support independent research initiatives that influence future clinical trial access.
The takeaway
The Artemis Project marks a shift toward independent, grassroots-funded medical research aimed at creating new prevention protocols. If you are managing a cancer diagnosis, it is worth discussing available federal resources with a provider to understand which current benefits you may be eligible to access.
Further reading
For more on the current research landscape, visit our Cancer section.
Source note: This article includes information reported by Los Angeles Times.
Live Poll
Should government-mandated waiting periods for metastatic cancer patients' disability benefits be permanently eliminated?
